News
The agency also revoked Sarepta's platform technology designation for AAVrh74 Friday and issued a safety communication saying ...
FDA places clinical hold on Sarepta's LGMD gene therapy trials after three deaths and revokes platform tech designation due ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results